Advertisement

Journal of Artificial Organs

, Volume 21, Issue 2, pp 125–131 | Cite as

Transcatheter heart valve for aortic valve implantation: republication of the article published in the Japanese Journal of Artificial Organs

  • Hideki Oshima
Review Artificial Valve

Abstract

This review was created based on a translation of the Japanese review first reported in the Japanese Journal of Artificial Organs in 2015 (vol. 44, no. 3, pp. 136–140), with some modifications.

Keywords

Transcatheter heart valve (THV) Transcatheter aortic valve implantation (TAVI) Balloon-expandable valve (BEV) Self-expandable valve (SEV) 

Notes

Compliance with ethical standards

Conflict of interest

The author has no COIs.

References

  1. 1.
    Bourantas CV, Serruys PW. Evolution of transcatheter aortic valve replacement. Circ Res. 2014;114:1037–51.CrossRefPubMedGoogle Scholar
  2. 2.
    Agarwal S, Tuzcu EM, Krishnaswamy A, Schoenhagen P, Stewart WJ, Svensson LG, et al. Transcatheter aortic valve replacement: current perspectives and future implications. Heart. 2015;101:169–77.CrossRefPubMedGoogle Scholar
  3. 3.
    Maeda K, Kuratani T, Torikai K, Mizote I, Ichibori Y, Onishi T, et al. New self-expanding transcatheter aortic valve device for transfemoral implantation—early results of the first-in-asia implantation of the ACURATE Neo/TF(TM) System. Circ J. 2015;79:1037–43.CrossRefPubMedGoogle Scholar
  4. 4.
    Barbanti M, Leipsic J, Binder R, Dvir D, Tan J, Freeman M, et al. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;63:976–81.CrossRefPubMedGoogle Scholar
  5. 5.
    Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.CrossRefPubMedGoogle Scholar
  6. 6.
    Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Schuler G, Schroeder R, Linke A. Heart leaflet technology valve. EuroIntervention. 2013;9:S115–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Généreux P, Head SJ, Hahn R, Daneault B, Kodali S, Williams MR, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36.CrossRefPubMedGoogle Scholar
  9. 9.
    Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.CrossRefPubMedGoogle Scholar
  10. 10.
    Schofer J, Colombo A, Klugmann S, Fajadet J, DeMarco F, Tchétché D, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63:763–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schröfel H, et al. First registry results from the newly approved ACURATE TA™ TAVI system†. Eur J Cardiothorac Surg. 2015;48:137–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Sündermann SH, Holzhey D, Bleiziffer S, Treede H, Falk V. Medtronic Engager™ bioprosthesis for transapical transcatheter aortic valve implantation. EuroIntervention. 2013;9:S97–100.CrossRefPubMedGoogle Scholar
  13. 13.
    Seiffert M, Conradi L, Kloth B, Koschyk D, Schirmer J, Schnabel RB, et al. Single-centre experience with next-generation devices for transapical aortic valve implantation. Eur J Cardiothorac Surg. 2015;47:39–45, (discussion).CrossRefPubMedGoogle Scholar
  14. 14.
    Binder RK, Schäfer U, Kuck KH, Wood DA, Moss R, Leipsic J, et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc Interv. 2013;6:301–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Gooley RP, Talman AH, Cameron JD, Lockwood SM, Meredith IT. Comparison of self-expanding and mechanically expanded transcatheter aortic valve prostheses. JACC Cardiovasc Interv. 2015;8:962–71.CrossRefPubMedGoogle Scholar
  16. 16.
    Watanabe Y, Hayashida K, Takayama M, Mitsudo K, Nanto S, Takanashi S. et.al. First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: the Massy study group vs. the PREVAIL JAPAN trial. J Cardiol. 2015;65:112–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Mizutani K, Hara M, Iwata S, Murakami T, Shibata T, Hayashida K, et al. Elevation of B-type natriuretic peptide at discharge is associated with 2-year mortality after transcatheter aortic valve replacement in patients with severe aortic stenosis: insights from a multicenter prospective OCEAN-TAVI (optimized transcatheter valvular intervention-transcatheter aortic valve implantation) registry. J Am Heart Assoc. 2017;6:1–10.CrossRefGoogle Scholar
  18. 18.
    Herrmann HC, Thourani VH, Kodali SK, Makkar RR, Szeto WY, Leon MB, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134:130–40.CrossRefPubMedGoogle Scholar
  19. 19.
    Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Morice MC, et al. Streamlining the learning process for TAVI: insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2018

Authors and Affiliations

  1. 1.Department of Cardiac SurgeryNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations